Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Geldanamycin derivative with selective activity against breast cancer developed at Sloan-Kettering

Nov. 26, 1999

New acylfulvene analogues with clinical potential identified by MGI Pharma

Nov. 26, 1999

WHI-D12 is a potent and selective inhibitor of Bruton's tyrosine kinase

Nov. 26, 1999

Abbott's new LHRH antagonists, pharmaceutical compositions and use

Nov. 26, 1999

Novel antitumor agents for both leukemias and solid tumors discovered by Taiwanese scientists

Nov. 26, 1999

Xenova's IND for multidrug resistance modulator gets FDA approval

Nov. 26, 1999

AACR-NCI-EORTC news: Japanese research team presents new hypoxic cell radiosensitizing agent

Nov. 25, 1999

Mount Sinai investigators describe novel apoptosis-inducing agent at scientific forum

Nov. 25, 1999

BASF discloses protein kinase inhibitors useful as antiangiogenic agents

Nov. 25, 1999

Calcium entry blockers with potential in the treatment of prostate cancer

Nov. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...